HKSH Proton Therapy Centre has demonstrated strong research depth on the international academic stage, injecting powerful ...
HKSH's first-in-Asia comparative study found hypofractionated proton therapy prevented breast cancer recurrence with a 100 ...
Mr. Wyman LI, Chief Operating Officer of HKSH Medical Group and Director of Hong Kong Sanatorium & Hospital (2nd right), Dr. Joseph CHAN, Chief Medical Officer, HKSH Medical Group and Deputy Medical ...
Hyperinflammation drives mortality in severe or critical viral pneumonia. We evaluated the association of ulinastatin, an immunomodulatory agent, with 28 day mortality in patients with severe or ...
Northwest Biotherapeutics (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies ...
The prognostic significance of the computed tomography (CT)-defined emphysema phenotype in patients hospitalized with mild-to-moderate acute exacerbation of chronic obstructive pulmonary disease ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results